Veradigm (Veradigm) Debt-to-Equity : 0.19 (As of Sep. 2022)

View and export this data going back to 1999. Start your Free Trial

What is Veradigm Debt-to-Equity?

Veradigm's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $6 Mil. Veradigm's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2022 was $213 Mil. Veradigm's Total Stockholders Equity for the quarter that ended in Sep. 2022 was $1,177 Mil. Veradigm's debt to equity for the quarter that ended in Sep. 2022 was 0.19.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Veradigm's Debt-to-Equity or its related term are showing as below:

MDRX's Debt-to-Equity is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 0.46
* Ranked among companies with meaningful Debt-to-Equity only.

Veradigm Debt-to-Equity Historical Data

The historical data trend for Veradigm's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veradigm Debt-to-Equity Chart

Veradigm Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Debt-to-Equity

Get a 7-Day Free Trial

0.84

0.43

0.80

0.17

0.31

Veradigm Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Debt-to-Equity	Get a 7-Day Free Trial															0.32	0.31	0.29	0.18	0.19

Competitive Comparison of Veradigm's Debt-to-Equity

For the Health Information Services subindustry, Veradigm's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Veradigm's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veradigm's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Veradigm's Debt-to-Equity falls into.

Veradigm Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Veradigm's Debt to Equity Ratio for the fiscal year that ended in Dec. 2021 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(19.599	+	414.884)	/	1408.138
	=	0.31

Veradigm's Debt to Equity Ratio for the quarter that ended in Sep. 2022 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.166	+	212.641)	/	1177.023
	=	0.19

Veradigm (OTCPK:MDRX) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Veradigm Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Veradigm's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Veradigm (Veradigm) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Veradigm Inc (OTCPK:MDRX) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

222 Merchandise Mart Plaza, Suite 2024, Chicago, IL, USA, 60654

Website

https://www.veradigm.com

Veradigm Inc is a healthcare technology company that drives value through its various combination of platforms, data, expertise, connectivity, and scale. It delivers a combination of point-of-care clinical and financial solutions. The Veradigm Network features a dynamic community of solutions and partners providing insights, technology, and data-driven solutions, all working together to transform healthcare insightfully.

Executives

Shih Yin Ho	director	222 MERCHANDISE MART, SUITE 2024, CHICAGO IL 60654
Susan Rodriguez	director	C/O ARDELYX, INC., 34175 ARDENWOOD BLVD, SUITE 200, FREMONT CA 94555
Richard J. Poulton	officer: CFO	3646 WESTFIELD LANE, GLENVIEW IL 60026
Tejal Vakharia	officer: SVP Gerneral Counsel	222 MERCHANDISE MART PLZ, SUITE 2024, CHICAGO IL 60654
David B Stevens	director	1 IMATION WAY, OAKDALE MN 55128
Leah Jones	officer: Chief Financial Officer	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Paul Black	director	400 WOOD ROAD, BRAINTREE MA 02184
Elizabeth Ann Altman	director	10070 BARNES CANYON ROAD, SAN DIEGO CA 92121
Thomas Langan	officer: President and CCO	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Lisa Hammond	officer: SVP & Chief HR Officer	305 CHURCH AT NORTH HILLS STREET, RALEIGH NC 27609
Greg Garrison	director	222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Lisa Khorey	officer: Chief Client Delivery Officer	222 MERCHANDISE MART PLAZA, CHICAGO IL 60654
Michael Klayko	director
Carol J Zierhoffer	director	100 NORTH POINT CENTER EAST, SUITE 200, ALPHARETTA GA 30022
Brian Farley	officer: SVP Gerneral Counsel & Corpora	222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654